Tobias Walbert
Tobias Walbert
Co-Director Hermelin Brain Tumor Center, Henry Ford Health Detroit
Dirección de correo verificada de hfhs.org - Página principal
TítuloCitado porAño
Health-related quality of life in patients with narcolepsy
R Dodel, H Peter, A Spottke, C Noelker, A Althaus, U Siebert, T Walbert, ...
Sleep medicine 8 (7-8), 733-741, 2007
1302007
The socioeconomic impact of narcolepsy
R Dodel, H Peter, T Walbert, A Spottke, C Noelker, K Berger, U Siebert, ...
Sleep 27 (6), 1123-1128, 2004
902004
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
TF Cloughesy, J Landolfi, DJ Hogan, S Bloomfield, B Carter, CC Chen, ...
Science translational medicine 8 (341), 341ra75-341ra75, 2016
882016
The role of chemotherapy in the treatment of patients with brain metastases from solid tumors
T Walbert, MR Gilbert
International journal of clinical oncology 14 (4), 299-306, 2009
652009
End-of-life symptoms and care in patients with primary malignant brain tumors: a systematic literature review
T Walbert, M Khan
Journal of neuro-oncology 117 (2), 217-224, 2014
642014
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study
M van Den Bent, HK Gan, AB Lassman, P Kumthekar, R Merrell, ...
Cancer chemotherapy and pharmacology 80 (6), 1209-1217, 2017
382017
Palliative and supportive care for glioma patients
T Walbert, K Chasteen
Current Understanding and Treatment of Gliomas, 171-184, 2015
372015
Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas
B Ellezam, BJ Theeler, T Walbert, AG Mammoser, C Horbinski, ...
Acta neuropathologica 124 (3), 449-451, 2012
352012
The impact of Accreditation Council for Graduate Medical Education duty hours, the July phenomenon, and hospital teaching status on stroke outcomes
A Alshekhlee, T Walbert, M DeGeorgia, DC Preston, AJ Furlan
Journal of Stroke and Cerebrovascular Diseases 18 (3), 232-238, 2009
322009
Durable Complete Responses in Some Recurrent High Grade Glioma Patients Treated with Toca 511 & Toca FC.
TF Cloughesy, J Landolfi, MA Vogelbaum, D Ostertag, JB Elder, ...
Neuro-oncology, noy075, 2018
312018
Integration of palliative care into the neuro-oncology practice: patterns in the United States
T Walbert
Neuro-oncology practice 1 (1), 3-7, 2014
292014
Recurrent high-grade glioma: a diagnostic and therapeutic challenge
T Walbert, T Mikkelsen
Expert review of neurotherapeutics 11 (4), 509-518, 2011
242011
Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma
T Walbert, MR Gilbert, MD Groves, VK Puduvalli, WKA Yung, CA Conrad, ...
Journal of neuro-oncology 102 (2), 273-280, 2011
242011
Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment
T Walbert, MD Groves
Future Oncology 6 (2), 287-297, 2010
232010
Systematic assessment of decision models in Parkinson's disease
U Siebert, B Bornschein, T Walbert, RC Dodel
Value in Health 7 (5), 610-626, 2004
232004
Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology: a North-American survey
T Walbert, M Glantz, L Schultz, VK Puduvalli
Journal of neuro-oncology 126 (2), 337-345, 2016
202016
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with : results from an international phase I multicenter trialegfr: results from an …
AB Lassman, MJ van den Bent, HK Gan, DA Reardon, P Kumthekar, ...
Neuro-oncology 21 (1), 106-114, 2019
16*2019
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I …
AB Lassman, MJ van den Bent, HK Gan, DA Reardon, P Kumthekar, ...
Neuro-oncology 21 (1), 106-114, 2018
162018
Symptomatic neurocutaneous melanosis and Dandy-Walker malformation in an adult
T Walbert, AE Sloan, ML Cohen, MZ Koubeissi
Journal of Clinical Oncology 27 (17), 2886-2887, 2009
142009
Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas
M Holdhoff, X Ye, JG Supko, LB Nabors, AS Desai, T Walbert, GJ Lesser, ...
Neuro-oncology 19 (6), 845-852, 2017
122017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20